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Abstract
Background: Decisions around planned ultrafiltration volumes are the only part of the haemodialysis prescription decided
upon at every session. Removing too much fluid or too little is associated with both acute symptoms and long-term
outcomes. The degree to which patients engage with or influence decision-making is not clear. We explored patient
perspectives of prescribing ultrafiltration volumes, their understanding of the process and engagement with it.
Methods: A questionnaire developed for this study was administered to 1077 patients across 10 UK Renal Units. Factor
analysis reduced the dataset into factors representing common themes. Relationships between survey results and factors
were investigated using regression models. ANCOVA was used to explore differences between Renal Units.
Results: Patients generally felt in control of their fluid management and that they were given the final say on planned
ultrafiltration volumes. Around half of the respondents reported they take an active role in their treatment. However,
respondents were largely unable to relate signs and symptoms to fluid management practice and a third said they would
not report common signs and symptoms to clinicians. A fifth of patients reported not to know how ultrafiltration volumes
were calculated. Patients responded positively to questions relating to healthcare staff, though with significant variation
between units, highlighting differences in perception of care.
Conclusions: Despite a lack of formal acknowledgement in fluid management protocols, patients have significant
involvement in decisions regarding fluid removal during dialysis. Furthermore, substantial gaps remain in patient
knowledge and engagement. Formalizing the role of patients in these decisions, including patient education,
may improve prescription and achievement of target weights.
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Introduction
Decisions around fluid management in haemodialysis
(HD) have a significant impact on both short- and long-
term outcomes [1–6]. Furthermore, deciding on the
planned ultrafiltration volume is the only part of the
dialysis prescription that is actively considered at every
single session. This centrality and frequency make deci-
sions relating to fluid management incredibly important.
Prescription of fluid removal in haemodialysis involves a
number of components. These include dialysis scheduling
and interventions like profiling ultrafiltration rates or di-
alysate sodium concentrations [7, 8], all of which aim to
avoid hypovolemia. Arguably the most important aspect is
the target weight. Target weight can be defined in a num-
ber of ways [9] but aims to prevent hypovolemia and
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chronic fluid overload, minimise patient symptoms and
prevent loss of residual kidney function [5]. Setting the
target weight too high will lead to fluid overload which is
associated with mortality [10]. Setting the target weight
too low leads to rates of fluid removal that exceed what
the body can compensate for. As well as leading to end-
organ hypoperfusion, the patient will be susceptible to
acute symptoms such as intradialytic hypotension (IDH)
which is linked to mortality [11, 12].
Target weights are largely managed by clinical assess-
ment, a practice that has remained fundamentally un-
changed since the inception of haemodialysis [13].
Technology to assist decision-making has been devel-
oped, most promising being bioimpedance spectroscopy,
but sufficient evidence to support adoption is lacking
[14, 15]. Approaches to managing target weights varies
dramatically between and even within renal units, both
in the UK and internationally [6, 16].
Achieving target weight is also important. In a study
of over 12,000 US patients, 21% regularly had a post-
dialysis weight over 2 kg above or below their target
weight [17]. Every kg difference between target weight
and achieved post-dialysis weight has been associated
with a 2.7-fold higher risk of mortality [18].
Despite considerable focus on improving management
of fluid removal on HD, the interaction of the patient
with decision making has been largely neglected. This is
notable. Clinical assessment, the basis of target weight
prescription, involves patient reported symptoms while
strong clinician-patient partnerships are clearly central
to achieving target weights. This study aimed to explore
patient perspectives of target weight management and
ultrafiltration in a large sample of haemodialysis patients
in renal units across the UK.
Materials and methods
Study design
We developed a cross-sectional survey which was ad-
ministered to in-centre HD patients in the UK. The
study was approved by the Health Research Authority
Research Ethics Committee (reference 17/SC/0596) and
reported in accordance with STROBE guidelines [19].
The study was conducted in accordance with the Declar-
ation of Helsinki. Informed consent was indicated by
completion of the questionnaire.
Questionnaire development
The content of the questionnaire was informed by a quali-
tative study involving 12 haemodialysis patients [20] and
relevant literature. Questionnaire items were reviewed
with five experts in renal care (including 1 patient).
The questionnaire was piloted with 11 haemodialysis
patients using a convenience sample and was then re-
vised accordingly. The final questionnaire consisted of
38 questions (19 Likert, 8 closed questions, 10 questions
about demographics and 1 free text box – Add-
itional file 1). Topics covered included patients’ percep-
tion of:
 Understanding of target weight
 Impact of poor fluid management
 Involvement in decision making
 Knowledge and reporting practices around
intradialytic signs and symptoms
 Impact of bad experiences upon subsequent fluid
removal decisions
 Patient perception of how staff understand their
fluid management
Questionnaire reliability & validity
The questionnaire underwent test-retest reliability testing
with 20 patients and a 2-week gap between assessments.
Nominal data was assessed by Cohen’s kappa, Likert-scale
data by weighted Cohen’s kappa. Content validity was
assessed by 6 relevant experts (Renal Dietitian, haemodi-
alysis patient in a professional advocacy role, three Ne-
phrologists and Clinical Scientist), using the content
validity index [21].
Participants
The inclusion criteria were in-centre haemodialysis pa-
tients, over 18 years old, who could understand and
complete the questionnaire which was only available in
English. All questionnaires were completed between
May 2018 and December 2019. At each renal unit, pa-
tients were recruited by convenience sampling. Research
nurses were encouraged to offer the questionnaire to all
eligible patients dialysing on a particular shift in a par-
ticular location to minimise selection bias. However, the
ability to approach patients across different shifts and lo-
cations was dependent on the practicalities and resource
availability at each renal unit. The questionnaires were
mostly completed during treatment, with an option to
complete at home if preferred. Research nurses facili-
tated completion of questionnaires when requested but
the research nurses were not part of study conception,
data input or analysis and were independent from the
patient’s clinical care team.
Data analysis
Defining predictor and outcome variables
Categorical predictors with more than two groups were
grouped into binary variables (age: 18–65, 66+ years;
ethnicity: Caucasian, non-Caucasian; education: up to
school age 16, above age 16; years since beginning HD:
up to 3, more than 3; daily urine output: less than a cup-
ful, more than a cupful).
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Knowledge scores were calculated by summing all cor-
rect responses to questions about the causes of intradia-
lytic fluid management signs and symptoms (out of 9).
Reporting totals were calculated by summing the num-
ber of symptoms patients stated they would report to
staff if they were to experience it (out of 7). For the
symptom knowledge and reporting totals, missing data,
“I don’t know” responses or incorrect responses were in-
ferred as not knowing/not reporting.
Factor structure of the questionnaire
Exploratory factor analysis (principal axis factoring with
varimax rotation) was used to determine the factor
structure of the Likert scale questions. Items were re-
moved if they had poor individual Kaiser-Meyer-Olkin
values or did not load substantially on to a factor. The
number of factors were extracted according to the scree
plot [22] with a Kaiser-Meyer-Olkin statistic of 0.776
(please see Additional file 2 for the list of questions in-
cluded in each factor, and their factor loadings). Internal
consistency reliability was assessed using Cronbach’s α
coefficient [23] for all Likert scale questions and for each
factor separately.
Weighted factor scores were generated for patients
who answered all, or all but 1, question within a factor
by multiplying the question factor loading by the raw
Likert-scale score for that question, and then calculating
the average for all questions within a factor.
Predicting patient perspectives and knowledge of fluid
management
We used multiple regression to explore relationships be-
tween demographic variables and weighted factor, know-
ledge and reporting scores. Weighted factor scores were
also used as predictors for total knowledge and reporting
scores but were not used to predict other weighted factor
scores [24]. The initial model included all predictors and
the most parsimonious model was retained. The models
were bootstrapped due to deviations from normality [25].
Exploring differences between renal units
Differences in weighted factor, knowledge and reporting
scores between renal units were assessed using analysis
of covariance (ANCOVA), controlling for demographics
and factor scores shown to be significant in the multiple
regression models. The models were bootstrapped due
to deviations of normality [25].
Statistical analysis
Little’s test of Missing Completely at Random was non-
significant confirmed data was missing completely at
random (p = 0.07) and pairwise deletion applied [26].




1077 participants completed the questionnaire across 10
UK renal units and the number in each unit is detailed
in Table 1. A range of 8–54% of the renal units’ in-
centre haemodialysis patients completed the question-
naire, which combined was 26% of all units’ patients. Pa-
tient characteristics are detailed in Table 2.
Reliability and validity
Following Altman’s classification, test-retest results indi-
cated that 7% of the questions had fair, 41% moderate,
44% good and 7% very good reliability [27]. The ques-
tionnaire had content validity with all items having a
content validity index score of 0.83 or above [21].
Patients’ experiences
The majority (79%) of patients felt they in control of their
fluid management. Furthermore, patients largely felt that
they were asked about (85%) and given the final say (82%)
in deciding how much fluid to remove, while 51% felt they
took an active role in their treatment or engaged with a
shared care program. Sixty six percent (66%) of patients
stated they had had an unpleasant experience during dia-
lysis due to having too much fluid removed, and 66% of
these patients believed this affected how much fluid they
were subsequently willing to have removed.
Reporting and knowledge of signs and symptoms
The ability to link common signs and symptoms to re-
moving too much or too little fluid varied quite substan-
tially. Only 14% of patients identified that an increased
risk of fistula failure could be related to removing too
much fluid during dialysis, whereas 59% of patients cor-
rectly answered that this could lead to cramping and a
rapid drop in blood pressure (Table 3).
Reporting of signs and symptoms also varied, with diz-
ziness most likely to be reported and thirst least likely to
be reported.
Target weight
Twenty percent (20%) of patients reported that they did
not know their target weight, yet 76% of patients agreed
that they understood how staff use their target weight to
work out how much fluid to remove during dialysis. Sev-
enty percent (70%) of patients agreed they would remove
more fluid than normal if they were fluid overloaded,
however 30% said they would be happy to remain fluid
overloaded in order to finish their dialysis session early.
Also, 56% of patients considered flexibility in their diet
and fluid restrictions as more important than getting to
their target weight at each dialysis session.
Keane et al. BMC Nephrology          (2021) 22:188 Page 3 of 10
Factor structure of the questionnaire
The scree plot suggested 3 factors to the solution: factor 1
“perception of staff understanding of the patient’s fluid
management”; factor 2 “patients’ perceived control of their
fluid management”; and factor 3 “self-reported knowledge
of the long-term effects of poor fluid management”.
Higher scores reflect better perceived staff understanding,
feeling more in control, or feeling more knowledgeable
about the long-term impacts. The questionnaire as a
whole as well as each individual factor had good internal
consistency (all Cronbach’s α > 0.7).
Predicting patient perspectives and knowledge of fluid
management
The variance explained by the models was small (1.3–
18.7%) but in each case significant. Non-Caucasian pa-
tients were more likely to rate staff understanding of
their own fluid management (factor 1) lower (Table 4).
For factor 2, older patients were predicted to score lower
on their perception of having control of their fluid man-
agement. For factor 3, women, patients who have previ-
ously had a kidney transplant, and patients with less
urine output were predicted to self-report greater know-
ledge about the long-term effects of poor fluid
management.
Better knowledge of the causes of common intradia-
lytic signs and symptoms was linked to younger age,
higher education, receiving dialysis for a greater num-
ber of years and rating staff understanding of fluid
management higher. Younger patients and patients
who rated staff understanding of their fluid manage-
ment higher were predicted to report more common
intradialytic signs and symptoms if they were to ex-
perience them.
Exploring differences between renal units
There were significant differences between Renal Units
on all outcomes in unadjusted analysis (ANOVA), which
remained when significant predictors were controlled for
(Fig. 1).
Discussion
By surveying patients’ views on target weight manage-
ment and ultrafiltration in haemodialysis we have fo-
cused on a largely neglected but nevertheless important
topic. Patients were generally satisfied with their care
and felt they had significant influence over decisions, yet
the data clearly shows that a large proportion of patients
lack knowledge and have misunderstandings about the
fundamentals of target weight management and pre-
scription of ultrafiltration volumes. This highlights an
opportunity to improve involvement in decision-making,
which may improve achievement of target weights and
associated outcomes [17].
One in five patients could not recall their target
weight, and similar numbers did not know how ultrafil-
tration volumes were calculated. Important gaps in
Table 1 Demographic characteristics of patients who
responded to the survey
Characteristic Total n (%) Range by renal unit (%)
Age (yrs)
18–25 23 (2%) 0–4%
26–35 40 (4%) 0–6%
36–45 79 (7%) 0–15%
46–55 163 (15%) 9–18%
56–65 235 (22%) 12–25%
66–75 252 (23%) 16–42%
76+ 260 (24%) 16–41%
Ethnicity
White 849 (79%) 72–96%
Black 56 (5%) 0–11%
Asian 119 (11%) 0–18%
Other 16 (2%) 0–3%
Sex
Male 663 (62%) 52–80%
Female 361 (34%) 10–40%
Education
Up to school age 16 427 (40%) 29–53%
Above school age 16 410 (38%) 23–50%
Comorbidities
Heart failure 190 (18%) 8–44%
Diabetes 375 (35%) 20–54%
Dialysis vintage (years)
< 1 236 (22%) 5–28%
1–3 347 (32%) 26–52%
3–5 177 (14%) 8–30%
5–10 150 (14%) 7–18%
> 10 128 (12%) 6–18%
Urine output
None 240 (22%) 9–37%
Less than a cupful per day 313 (29%) 24–40%
More than a cupful per day 487 (45%) 37–52%
HD sessions per week
< 3 30 (3%) 0–8%
3 991 (92%) 78–100%
> 3 26 (2%) 4–19%
Previous kidney transplant
Yes 184 (17%) 6–22%
No 854 (79%) 71–89%
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knowledge about the causes of common signs and symp-
toms were evident across the population, with younger
age, increased education and increased time on dialysis
being associated with better knowledge. Almost half of
surveyed patients limit ultrafiltration volumes based on
previous unpleasant experiences. It is also notable that
64 and 54% of patients felt they were aware of the long
term impact of regularly not removing enough fluid or
removing too much respectively. Patients also over-
whelmingly felt that they are consulted and even given
the final say in how much fluid is removed at each ses-
sion. This strongly highlights the need to address know-
ledge gaps and contextualize previous experiences to
ensure that patients make a truly informed decision
when influencing ultrafiltration targets.
Our results are broadly consistent with previous work.
The proportion of patients knowing their target weight
is similar to findings in US patients [28] and the differ-
ences between units reflect international differences
[29]. Younger age and higher education have also previ-
ously been linked to patients’ knowledge of haemodialy-
sis [30]. However, unlike our results, a study of
Norwegian patients suggested some patients feel their
input into decisions around fluid removal on HD is not
considered [31].
Relatively few patients felt that they would report signs
and symptoms of fluid volume disturbance to staff. Not
only will this directly impact on managing the patient’s
target weight, but symptom reporting has been shown to
prompt partnership between patients and the dialysis
team [32, 33]. A formal approach to incorporating
patient reported symptoms into fluid management deci-
sions, such as the Recova® tool [34], may help to improve
regular and systematic input of patient symptoms into
decision making. Our results suggest that underreport-
ing of symptoms is associated with older age and having
less confidence in the clinical team. Previous work simi-
larly noted that limited or conflicting staff knowledge of
Table 2 Study cohort by renal unit and as a proportion of the total HD population of the unit
Renal unit Patients included in the study Total HD patients at the unita Proportion (%)
1 292 538 54%
2 47 549 9%
3 182 387 47%
4 150 500 30%
5 50 183 27%
6 184 899 20%
7 27 352 8%
8 20 128 16%
9 69 423 16%
10 56 160 35%
aNote, not all dialysis locations under the care of each unit were included, leading to the high range in proportions
Table 3 Knowledge and reporting of signs and symptoms; n (%)
Symptom Correctly identifies if symptom is related to removing too much fluid
or having too much fluid in your body
Would routinely report this symptom to staff
if this symptom occurred
Swollen tissue 627 (58%) 715 (66%)
Feeling very tired
after dialysis
469 (44%) 685 (64%)




Shortness of breath 479 (44%) 784 (73%)
Passing less urine 351 (33%) 524 (49%)
Thirst 415 (39%) 466 (52%)a
Cramping 634 (59%) 754 (70%)
A rapid drop in
blood pressure
634 (59%) –
aDue to printing errors in one of the units, the question relating to whether patients report thirst was incomprehensible and so was removed from analysis,
leaving only 893 completed responses for this specific item
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the causes of symptoms could reduce reporting of HD-
related symptoms and that this could contribute to
patients feeling uncertain about the causes of their
symptoms [35].
UK guidelines acknowledge the importance of patients
understanding their symptoms and how they can be
managed and also recommend that healthcare profes-
sionals routinely ask patients about their symptoms and
Fig. 1 Adjusted means & bootstrapped standard errors for each renal unit after controlling for significant predictors. All differences p < 0.05 from
ANCOVA models. Number of completed questionnaires at each unit is indicated in the axis label
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explain possible causes of these [36]. Although we did
not collect data on healthcare professionals’ practice, it
is clear from the patients’ perspective that they may not
consider there is routine dialogue around symptoms or
good understanding of their cause.
Three factors were generated by the factor analysis.
Patients generally perceived that staff understood their
fluid management, although non-Caucasian patients to a
lesser extent. Difficulties in developing patient-clinician
relationships has been reported by patients from non-
Caucasian communities [37], including UK haemodialy-
sis patients [38]. Whilst language barriers have been re-
ported as one possible factor, our study excluded
patients with language barriers, highlighting the need for
further exploration. Considering the second factor, older
patients felt less in control of their fluid management,
similar to previous findings [30]. Finally, female gender,
previous kidney transplantation and lower urine output
were associated with greater knowledge of the long term
effects of poor fluid management. Interestingly, these were
different variables to those associated with the objective
test of knowledge about common dialysis symptoms.
A survey to assess UK clinician practice patterns
highlighted significant differences between renal units
in fluid management [16] and some of the results for
units from this study can be seen in Table 5. It is
Table 4 Bootstrapped multiple regression identifying predictors for knowledge and reporting of signs and symptoms. Beta values















Knowledge of signs and
symptoms
n = 697
Reporting of signs and
symptoms
n = 869
Δ R [2] .01b .02b .03b 0.19b .02b
Age (66+ years) −0.07 [− 0.1, −
0.01]a
−1.7 [−2.1, − 1.4]b − 0.4 [− 0.7, − 0.1]a
Ethnicity (non-Caucasian) −0.1 [− 0.2, − 0.04]b
Gender (female) 0.103 [0.02, 0.2]a
Education (High) 1.0 [0.6, 1.3]b
Years since first HD (3+
years)
0.06 [0.01, 0.1] 0.04 [−0.05, 0.1] 0.8 [0.5, 1.1]b
Previous kidney
transplant (yes)
−0.05 [− 0.1, − 0.002] −0.07 [− 0.1,
0.004]
−0.1 [− 0.2, − 0.03]a
Urine output (more) −0.1[− 0.2, 0.003]a
Weighted Factor 1 1.0 [0.4, 1.5]b 0.8 [0.3, 1.2]b
Weighted Factor 2
Weighted Factor 3
a indicates significance at the 0.05 level, b indicates significance at the 0.01 level
Table 5 Practice patterns of fluid management in the renal units from this survey, using data from the study by Dasgupta et al. (16).
Renal units 5, 7 and 10 did not participate in the practice patterns study. BCM is Body Composition Monitor, a bioimpedance device
(Fresenius Medical Care), and RBV is relative blood volume monitoring
Survey question Renal Unit
1 2 3 4 6 9 10
Does your unit have an agreed policy /guidelines for fluid
management?
Yes No No Yes No No No
Is the fluid status of an HD patient routinely assessed on
the dialysis unit?
No Yes Yes Yes No Yes Yes
Who is mainly responsible for the routine assessment of
an HD patient’s fluid status?




N/a Senior nurse Nurse
Who is mainly responsible when there are concerns






Frequency of routine dry weight review in the absence of
clinical concerns?
Quarterly Quarterly Quarterly Weekly Monthly Monthly Weekly
Do you use technology to assess fluid status? BCM RBV No RBV RBV No RBV
How do you have a strategy for advice on fluid and salt
restrictions?
No Yes Yes No Yes No Yes
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therefore unsurprising that we demonstrated signifi-
cant between-unit differences in factor scores, know-
ledge and reporting of signs and symptoms (Fig. 1).
Acknowledging the role that the patient has in this
process in local standard operating procedures and
national guidelines could work towards reducing these
differences.
UK Patient Reported Experience Measures have shown
that “shared decisions around your care” is one of the low-
est rated aspects of care in haemodialysis [39] and we
know it is a priority area for kidney patients and nephrolo-
gists [40, 41]. Good participation in care for dialysis pa-
tients is at its core based on information sharing [42, 43].
Patient expertise can be facilitated by patients challenging
clinicians’ decisions [42], although patients can find these
interactions adversarial and confrontational [44]. Allo-
cated time and space for meaningful patient-clinician in-
teractions is clearly needed.
Our results strongly support the need for considered
education for patients and for staff who are central to
meeting patients’ educational needs [32]. Although
broader in scope than fluid management, the SHARE-HD
program is a good example of formalized, education-
enabled participation in routine haemodialysis care [45].
Strengths and limitations
This is the first study with a primary objective of under-
standing patient perspectives of target weight manage-
ment and ultrafiltration in haemodialysis. We surveyed a
large cohort from a broad range of UK Renal Units that
was reflective of ethnicities in the UK haemodialysis
population as a whole. Nevertheless generalizability was
limited by our exclusion of patients without good com-
prehension of the English language. As the question-
naires were predominately with staff in the near vicinity,
we cannot discount an impact upon patients’ responses.
Nonetheless, patients did have the choice to complete
the questionnaire at home and all questionnaires were
anonymous. We also acknowledge the risk of selection
bias from the characteristics of patients that research
nurses approached and those more likely to be willing to
participate, though the age, gender and ethnicity of the
included participants in each unit is comparable to the
unit population as a whole (Supplementary Table 2).
Conclusion
We have demonstrated that haemodialysis patients in
the UK feel that they are routinely included in decisions
regarding fluid removal during dialysis. However, there
are significant gaps in patient knowledge and under-
standing of the fundamentals of fluid management and
prescription of ultrafiltration volumes which could lead
to sub-optimal care. Differences between units were also
demonstrated. Formalizing the role patients have in the
decisions, ensuring appropriate patient education is in
place and ensuring opportunities for genuine patient-
clinician interaction could provide opportunities to ad-
dress the longstanding challenge to improve fluid-related
outcomes in haemodialysis.
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